Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Diabetes Is Associated With Increased Liver Cancer Incidence and Mortality in Adults: A Report From Asia Cohort Consortium Publisher



Ho NT1 ; Abe SK2 ; Rahman MS2, 3 ; Islam R2, 4 ; Saito E5 ; Gupta PC6 ; Pednekar MS6 ; Sawada N7 ; Tsugane S7, 8 ; Tamakoshi A9 ; Kimura T9 ; Shu XO10 ; Gao YT11 ; Koh WP12, 13 Show All Authors
Authors
  1. Ho NT1
  2. Abe SK2
  3. Rahman MS2, 3
  4. Islam R2, 4
  5. Saito E5
  6. Gupta PC6
  7. Pednekar MS6
  8. Sawada N7
  9. Tsugane S7, 8
  10. Tamakoshi A9
  11. Kimura T9
  12. Shu XO10
  13. Gao YT11
  14. Koh WP12, 13
  15. Cai H10
  16. Wen W10
  17. Sakata R14
  18. Tsuji I15
  19. Malekzadeh R16
  20. Pourshams A17
  21. Kanemura S15
  22. Kim J18
  23. Chen Y19
  24. Ito H20, 21
  25. Oze I20
  26. Nagata C22
  27. Wada K22
  28. Sugawara Y23
  29. Park SK24
  30. Shin A24, 25
  31. Yuan JM26, 27
  32. Wang R26
  33. Kweon SS28
  34. Shin MH28
  35. Poustchi H29
  36. Vardanjani HM30
  37. Ahsan H31
  38. Chia KS32
  39. Matsuo K33, 34
  40. Qiao YL35
  41. Rothman N36
  42. Zheng W37
  43. Inoue M2
  44. Kang D38
  45. Boffetta P39, 40
Show Affiliations
Authors Affiliations
  1. 1. Research Management Department, Vinmec Healthcare System, Hanoi, Viet Nam
  2. 2. Division of Prevention, National Cancer Center Institute for Cancer Control, Tokyo, Japan
  3. 3. Research Center for Child Mental Development, Hamamatsu University School of Medicine, Hamamatsu, Japan
  4. 4. Hitotsubashi Institute for Advanced Study, Hitotsubashi University, Tokyo, Japan
  5. 5. Institute for Global Health Policy Research, National Center for Global Health and Medicine, Tokyo, Japan
  6. 6. Healis—Sekhsaria Institute for Public Health, Navi Mumbai, India
  7. 7. Division of Cohort Research, National Cancer Center Institute for Cancer Control, Tokyo, Japan
  8. 8. Graduate School of Public Health, International University of Health and Welfare, Tokyo, Japan
  9. 9. Department of Public Health, Hokkaido University Faculty of Medicine, Sapporo, Japan
  10. 10. Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, United States
  11. 11. Department of Epidemiology, Shanghai Cancer Institute Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
  12. 12. Healthy Longevity Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
  13. 13. Singapore Institute for Clinical Sciences, Agency for Science Technology and Research (A*STAR), Singapore, Singapore
  14. 14. Radiation Effects Research Foundation, Hiroshima, Japan
  15. 15. Tohoku University Graduate School of Medicine, Sendai, Japan
  16. 16. Digestive Oncology Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran
  17. 17. Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran
  18. 18. Graduate School of Cancer Science and Policy, National Cancer Center, Goyang-si, South Korea
  19. 19. Department of Population Health and Environmental Medicine, New York University, New York, NY, United States
  20. 20. Division of Cancer Information and Control, Department of Preventive Medicine, Aichi Cancer Center Research Institute, Nagoya, Japan
  21. 21. Division of Descriptive Cancer Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, Japan
  22. 22. Department of Epidemiology and Preventive Medicine, Gifu University Graduate School of Medicine, Gifu, Japan
  23. 23. Department of Health Informatics and Public Health, Division of Epidemiology, Tohoku University Graduate School of Public Health, Sendai, Japan
  24. 24. Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, South Korea
  25. 25. Cancer Research Institute, Seoul National University, Seoul, South Korea
  26. 26. Division of Cancer Control and Population Sciences, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, United States
  27. 27. Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, United States
  28. 28. Department of Preventive Medicine, Chonnam National University Medical School, Gwangju, South Korea
  29. 29. Digestive Disease Research institute Tehran University of Medical Science, Tehran, Iran
  30. 30. MD-MPH Dual Degree Program, School of Medicine, Research Center for Traditional Medicine and History of Medicine, Shiraz University of Medical Science, Shiraz, Iran
  31. 31. Department of Public Health Sciences, University of Chicago, Chicago, IL, United States
  32. 32. Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore
  33. 33. Division of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan
  34. 34. Department of Cancer Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, Japan
  35. 35. School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
  36. 36. Division of Cancer Epidemiology and Genetics, Occupational and Environmental Epidemiology Branch, National Cancer Institute, Bethesda, MD, United States
  37. 37. Division of Epidemiology, Vanderbilt-Ingram Cancer Center, Vanderbilt Epidemiology Center, Vanderbilt University Medical Center, Nashville, TN, United States
  38. 38. Seoul National University College of Medicine, Seoul, South Korea
  39. 39. Stony Brook Cancer Center, Stony Brook University, New York, NY, United States
  40. 40. Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy

Source: International Journal of Cancer Published:2024


Abstract

There has been growing evidence suggesting that diabetes may be associated with increased liver cancer risk. However, studies conducted in Asian countries are limited. This project considered data of 968,738 adults pooled from 20 cohort studies of Asia Cohort Consortium to examine the association between baseline diabetes and liver cancer incidence and mortality. Cox proportional hazard model and competing risk approach was used for pooled data. Two-stage meta-analysis across studies was also done. There were 839,194 subjects with valid data regarding liver cancer incidence (5654 liver cancer cases [48.29/100,000 person-years]), follow-up time and baseline diabetes (44,781 with diabetes [5.3%]). There were 747,198 subjects with valid data regarding liver cancer mortality (5020 liver cancer deaths [44.03/100,000 person-years]), follow-up time and baseline diabetes (43,243 with diabetes [5.8%]). Hazard ratio (HR) (95% confidence interval [95%CI]) of liver cancer diagnosis in those with vs. without baseline diabetes was 1.97 (1.79, 2.16) (p <.0001) after adjusting for baseline age, gender, body mass index, tobacco smoking, alcohol use, and heterogeneity across studies (n = 586,072; events = 4620). Baseline diabetes was associated with increased cumulative incidence of death due to liver cancer (adjusted HR (95%CI) = 1.97 (1.79, 2.18); p <.0001) (n = 595,193; events = 4110). A two-stage meta-analytic approach showed similar results. This paper adds important population-based evidence to current literature regarding the increased incidence and mortality of liver cancer in adults with diabetes. The analysis of data pooled from 20 studies of different Asian countries and the meta-analysis across studies with large number of subjects makes the results robust. © 2024 UICC.
Experts (# of related papers)
Other Related Docs